News for eFFECTOR Therapeutics, Inc. (EFTR)

**media[485416]**

Tyra Biosciences names Doug Warner as new Chief Medical Officer

eFFECTOR Therapeutics to wind down operations and delist from Nasdaq

Loading... Loading... U.S. stocks traded mixed midway through trading, with the Dow Jones index gaining more than 300 points on Monday. The Dow traded up 0.80...

MadamLead eFFECTOR Therapeutics (NASDAQ:EFTR) on Monday said that it has terminated its employees and will wind down it operations, as it looks for...

SOLANA BEACH, Calif. and REDWOOD CITY, Calif., June 24, 2024 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ:EFTR) today announced that the Company has terminated its employees and will wind down it operations,

EFTR stock results show that eFFECTOR Therapeutics met analyst estimates for earnings per share the first quarter of 2024.

Dose escalation of zotatifin in the ZFA triplet ongoing at 0.14 mg/kg, with RP2D expected in H2 2024 Raised $15.0 million in gross proceeds from...

SOLANA BEACH, Calif. and REDWOOD CITY, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in the development...

eFFECTOR Therapeutics (EFTR) plunges on disappointing top-line results from the primary analysis of its mid-stage NSCLC study of tomivosertib, following the abandonment of the developmental program.

Shares of bluebird bio, Inc. (NASDAQ: BLUE) rose sharply during Monday’s session after the company presented updated data from its gene therapy program in transfusion-dependent beta-thalassemia at the 65th American Society of Hematology (ASH) Annual Meeting & Exposition.

Edible Garden AG Incorporated (NASDAQ: EDBL) shares fell on Monday following third-quarter results.

Zotatifin continued to demonstrate favorable activity and tolerability, including two previously reported confirmed partial responses (PRs) among seven...

On Thursday, 550 companies achieved new lows for the year.

Gainers Symbotic Inc. (NASDAQ: SYM) shares surged 120.6% to settle at $20.07 on Wednesday. Symbotic reported the completion of its business combination with SVF Investment Corp. to become a publicly traded company.

Gainers HeartCore Enterprises, Inc. (NASDAQ: HTCR) shares gained 81% to $1.8503 after the company authorized a $3.5 million buyback.

Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) shares gained 100.4% to close at $4.75 on Monday after the FDA granted clearance for the company's pūrgo technology, classifying it as a class II medical device.

Read Stock Analysts’ Upgrades for June 3rd (AI, ATNM, AXL, BANF, BPOP, CHUY, DLTH, EFTR, EONGY, ESEA) at ETF Daily News

Read eFFECTOR Therapeutics (NASDAQ:EFTR) Upgraded by Zacks Investment Research to “Buy” at ETF Daily News